GlucoTrack
GCTK
3 hedge funds and large institutions have $60.2K invested in GlucoTrack in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 6 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
57% less funds holding
Funds holding: 7 → 3 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
78% less capital invested
Capital invested by funds: $273K → $60.2K (-$213K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$24.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$15.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$204K |
| 2 |
AWM
Accurate Wealth Management
Wesley Chapel,
Florida
|
-$18.1K |
| 3 |
VCM
Virtue Capital Management
Brentwood,
Tennessee
|
-$12.6K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$7.27K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.52K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AF
1
Alerus Financial
Grand Forks,
North Dakota
| $27.8K | – | – | – |
|
|
2
Cetera Investment Advisers
Schaumburg,
Illinois
| $20.1K | +$24.1K | +8 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $12.2K | +$15.1K | +5 | New |
|
|
SM
4
Sabby Management
Miami Beach,
Florida
| – | -$204K | -102 | Closed |
|
|
VCM
5
Virtue Capital Management
Brentwood,
Tennessee
| – | -$12.6K | -5 | Closed |
|
|
AWM
6
Accurate Wealth Management
Wesley Chapel,
Florida
| – | -$18.1K | -4 | Closed |
|
|
7
Citadel Advisors
Miami,
Florida
| – | -$7.27K | -4 | Closed |
|
8
Renaissance Technologies
New York
| – | -$4K | -2 | Closed |
|
|
9
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$4.52K | -2 | Closed |
|
GCTK Hedge Fund Activity: Q2 2024 in Review
3 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q2 2024, worth a combined $60.2K — down 78% from $273K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of GCTK and 2 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Cetera Investment Advisers, opening a new position worth an estimated $24.1K. The largest seller was Sabby Management, exiting entirely with an estimated $204K sold.
- 3 institutional investors held GlucoTrack (GCTK) as of Q2 2024, down from 7 in Q1 2024.
- Funds reported $60.2K of GlucoTrack stock for Q2 2024, down 78% quarter-over-quarter.
- 2 funds opened new GlucoTrack positions in Q2 2024 and 6 closed out, a net change of -4 holders.
- The largest GlucoTrack buyer in Q2 2024 was Cetera Investment Advisers, an estimated $24.1K added.
- The largest GlucoTrack seller in Q2 2024 was Sabby Management, an estimated $204K sold.
Based on aggregated 13F filings for Q2 2024.